Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Coccidioidomycosis
ADR ID BADD_A00966
ADR Hierarchy
11      Infections and infestations
11.03      Fungal infectious disorders
11.03.09      Coccidioides infections
11.03.09.001      Coccidioidomycosis
22      Respiratory, thoracic and mediastinal disorders
22.07      Respiratory tract infections
22.07.08      Fungal lower respiratory tract infections
22.07.08.004      Coccidioidomycosis
Description Infection with a fungus of the genus COCCIDIOIDES, endemic to the SOUTHWESTERN UNITED STATES. It is sometimes called valley fever but should not be confused with RIFT VALLEY FEVER. Infection is caused by inhalation of airborne, fungal particles known as arthroconidia, a form of FUNGAL SPORES. A primary form is an acute, benign, self-limited respiratory infection. A secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. It can be detected by use of COCCIDIOIDIN. [MeSH]
MedDRA Code 10009825
MeSH ID D003047; D003047; D003047
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Chronic pulmonary coccidioidomycosis | Coccidioides immitis infection | Coccidioidomycosis | Coccidioidomycosis, unspecified | Other forms of progressive coccidioidomycosis | Primary coccidioidomycosis (pulmonary) | Primary extrapulmonary coccidioidomycosis | Pulmonary coccidioides | Pulmonary coccidioides chronic | Pulmonary coccidioidomycosis, unspecified | Coccidiodes pulmonary recurrent | Coccidiodomycosis recurrent | San Joaquin valley fever | Coccidioides posadasii infection | Coccidioidomycoses | Valley Fever | Valley Fevers | Coccidioides immitis Infection | Coccidioides immitis Infections | Infection, Coccidioides immitis | Infections, Coccidioides immitis | San Joaquin Valley Fever
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00156Apremilast0.004632%
BADD_D00285Bosentan0.000447%
BADD_D00416Certolizumab pegol--
BADD_D00551Cyclosporine0.001817%
BADD_D00912Fluconazole0.000081%
BADD_D01157Infliximab--
BADD_D01834Prednisone0.000042%
BADD_D02105Tacrolimus0.004258%
BADD_D02236Tofacitinib0.001737%
The 1th Page    1    Total 1 Pages